CKD Bio Corp. (063160) Stock Statistics & Valuation Metrics

CKD Bio Corp. has a market cap or net worth of ₩71.43B. The enterprise value is $249.52K.

CKD Bio Corp. has 5,485,962 shares outstanding. The number of shares has decreased by -2.65% in one year.

CKD Bio Corp.’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 1.28%.

The current PE Ratio of CKD Bio Corp. is ―. CKD Bio Corp.’s PEG ratio is 0.29.

In the last 12 months, CKD Bio Corp. had revenue of 160.07B and earned -2.89B in profits. Earnings per share was -526.16.

In the last 12 months, operating cash flow was 1.58B and capital expenditures -9.19B, giving a free cash flow of -7.60B billion.

CKD Bio Corp. pays an annual dividend of ―, resulting in a dividend yield of ―

CKD Bio Corp. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).

CKD Bio Corp. as a current ratio of 0.90, with Debt / Equity ratio of 118.15%

In the past 12 months, CKD Bio Corp. has paid -78.27M in taxes.

CKD Bio Corp. EV to EBITDA ratio is 13.25, with an EV/FCF ratio of -23.31.

CKD Bio Corp. has ₩1.03B in cash and marketable securities with ₩147.68B in debt, giving a net cash position of -₩146.66B billion.

Gross margin is 13.93%, with operating margin of 2.25%, and net profit margin of -1.80%.

The average price target for CKD Bio Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―